Stockscreener 앱 받기
1.99
0.51%
0.01
시간 외 거래:
2.04
0.05
+2.51%
전일 마감가:
$1.98
열려 있는:
$1.95
하루 거래량:
401.34K
Relative Volume:
0.24
시가총액:
$4.49M
수익:
-
순이익/손실:
$-6.91M
주가수익비율:
-0.6104
EPS:
-3.26
순현금흐름:
$-6.14M
1주 성능:
+8.74%
1개월 성능:
+9.94%
6개월 성능:
-32.10%
1년 성능:
-46.16%
1일 변동 폭
$1.79
$2.09
1주일 범위
$1.61
$2.09
52주 변동 폭
$1.15
$23.80
Galmed Pharmaceuticals Ltd Stock (GLMD) Company Profile
GLMD을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
GLMD
Galmed Pharmaceuticals Ltd
|
1.99 | 4.47M | 0 | -6.91M | -6.14M | -3.26 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.65 | 121.28B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.10 | 60.96B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.81 | 42.77B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.99 | 36.21B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.47 | 32.08B | 3.81B | -644.79M | -669.77M | -6.24 |
Galmed Pharmaceuticals Ltd Stock (GLMD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2020-05-22 | 다운그레이드 | B. Riley FBR | Buy → Neutral |
| 2020-02-04 | 개시 | Craig Hallum | Buy |
| 2020-01-30 | 재개 | Cantor Fitzgerald | Overweight |
| 2019-12-02 | 개시 | Canaccord Genuity | Buy |
| 2018-12-12 | 개시 | B. Riley FBR | Buy |
| 2018-08-02 | 재확인 | Maxim Group | Buy |
| 2018-07-13 | 개시 | Stifel | Buy |
| 2018-07-12 | 개시 | Cantor Fitzgerald | Overweight |
| 2018-06-12 | 재확인 | H.C. Wainwright | Buy |
| 2018-03-15 | 업그레이드 | Maxim Group | Hold → Buy |
| 2018-02-14 | 다운그레이드 | Maxim Group | Buy → Hold |
| 2018-02-12 | 재확인 | H.C. Wainwright | Buy |
| 2017-11-15 | 개시 | ROTH Capital | Buy |
| 2017-08-08 | 재확인 | H.C. Wainwright | Buy |
| 2017-07-31 | 재확인 | Maxim Group | Buy |
| 2016-08-01 | 재확인 | Maxim Group | Buy |
| 2016-07-06 | 재개 | ROTH Capital | Buy |
| 2016-03-28 | 재개 | H.C. Wainwright | Buy |
| 2015-06-23 | 개시 | H.C. Wainwright | Buy |
| 2015-05-06 | 개시 | Sun Trust Rbsn Humphrey | Buy |
모두보기
Galmed Pharmaceuticals Ltd 주식(GLMD)의 최신 뉴스
What is Galmed Pharmaceuticals Ltd. company’s growth strategyInvest confidently with real-time data analysis - jammulinksnews.com
Should I hold or sell Galmed Pharmaceuticals Ltd. stock in 2025Get real-time alerts on top-performing stocks - jammulinksnews.com
Why is Galmed Pharmaceuticals Ltd. stock attracting strong analyst attentionStrong return on assets - jammulinksnews.com
How does Galmed Pharmaceuticals Ltd. generate profit in a changing economyAchieve rapid wealth accumulation with smart picks - jammulinksnews.com
What is the risk reward ratio of investing in Galmed Pharmaceuticals Ltd. stockMaximize your returns with portfolio optimization - jammulinksnews.com
Is Galmed Pharmaceuticals Ltd. Stock a Good Fit for Conservative InvestorsReal Time Breakout Tracking - Newser
Is Galmed Pharmaceuticals Ltd. Stock Overbought or Oversold RSI Indicator AnalysisFree Market Analysis Group - Newser
Why Galmed Pharmaceuticals Ltd. stock attracts strong analyst attentionHigh Return Potential - Newser
What makes Galmed Pharmaceuticals Ltd. stock price move sharplyFree Professional Portfolio Management - Newser
Galmed Pharmaceuticals (NASDAQ:GLMD) Upgraded to Hold at Wall Street Zen - Defense World
What drives Galmed Pharmaceuticals Ltd. stock priceExceptional profit potential - PrintWeekIndia
Galmed Pharmaceuticals to Hold Special Meeting on Share Capital Increase - TipRanks
What analysts say about Galmed Pharmaceuticals Ltd. stockFree Stock Market Beginners Guide - Autocar Professional
Galmed Pharmaceuticals Ltd. Stock Analysis and ForecastMarket-crushing stock picks - Autocar Professional
Is Galmed Pharmaceuticals Ltd. a good long term investmentTurbocharged investment results - jammulinksnews.com
The Role of News and Events in Galmed Pharmaceuticals Ltd Inc. (GLMD) Price Performance - investchronicle.com
Why India’s Pharmaceutical Stocks Are on the Rise High Accuracy Trade SignalsRapid market gains - PrintWeekIndia
Solara Active Pharma Sciences Limited (SOLARAPP)’s Trend in 2025Free Stock Market Forecast Reports - jammulinksnews.com
PLAB Stock Analysis and ForecastSkyrocketing profit margins - jammulinksnews.com
How Galmed Pharmaceuticals Ltd. stock performs during market volatilityHigh Confidence Trade Setups - Newser
Galmed Pharmaceuticals Ltd. to Host Earnings Call - ACCESS Newswire
Galmed Identifies Proprietary Biomarker Signature for Aramchol, Unlocking Multi-Billion-Dollar Expansion Potential Beyond Nash - marketscreener.com
Galmed Pharmaceuticals Unveils Biomarker Signature for Aramchol, Expanding Market Potential - TipRanks
Galmed Identifies Proprietary Biomarker Signature for Aramchol, Unlocking Multi-Billion-Dollar Expansion Potential Beyond NASH - Longview News-Journal
Galmed Pharmaceuticals Ltd (GLMD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.97%
0.22%
자본화:
|
볼륨(24시간):